Exelixis Inc (NAS:EXEL)
$ 20.91 -0.32 (-1.51%) Market Cap: 6.09 Bil Enterprise Value: 5.42 Bil PE Ratio: 32.52 PB Ratio: 2.90 GF Score: 92/100

Exelixis Inc at Stifel Healthcare Conference Transcript

Nov 19, 2019 / 02:10PM GMT
Release Date Price: $16.53 (+1.85%)
Stephen Douglas Willey
Stifel, Nicolaus & Company, Incorporated, Research Division - Director

All right. So we're going to go ahead and get started. I'm Stephen Willey, one of the senior biotech analysts here at Stifel. As part of our next presentation, we have the CEO from Exelixis, Michael Morrissey. With him in attendance is Susan Hubbard, who runs up their communications effort; Chris Senner, who's their Chief Financial Officer; and Andrew Peters, who heads up their BD function.

We're just going to go right into a fireside chat. This is designed to be interactive. So if anyone has a question, feel free to [take] yourself, and hopefully, we'll get it asked.

Mike, I'm not sure if you want to make any kind of introductory comments with respect to kind of where you are, maybe what you do, and then we'll go right into Q&A.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

All right. Awesome. Good morning, everybody. Before I begin, I'll just start by saying that I'll be making forward-looking statements. So please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot